Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Prospective Observational Study to Evaluate the Effectiveness and Safety of JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive Gastroesophageal Reflux Disease

NCT07115706 is registered in ClinicalTrials.gov with Jeil Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07115706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Prospective Observational Study to Evaluate the Effectiveness and Safety of JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive Gastroesophageal Reflux Disease
Lead sponsor
Jeil Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
August 25, 2025
Completion date
July 31, 2026
Enrollment
7,150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

erosive gastroesophageal reflux disease